133 related articles for article (PubMed ID: 18309)
61. [Chronic-inflammatory intestinal diseases. Clinical picture, complications, differential diagnosis and nonsurgical therapy].
Fahrländer H
Chirurg; 1977 Sep; 48(9):557-62. PubMed ID: 20282
[No Abstract] [Full Text] [Related]
62. Current management of inflammatory bowel disease.
Selby W
J Gastroenterol Hepatol; 1993; 8(1):70-83. PubMed ID: 8094984
[TBL] [Abstract][Full Text] [Related]
63. Mechanisms of action of cholestyramine in the treatment of hypercholesterolemia.
Nazir DJ; Horlick L; Kudchodkar BJ; Sodhi HS
Circulation; 1972 Jul; 46(1):95-102. PubMed ID: 5039828
[No Abstract] [Full Text] [Related]
64. Inflammatory bowel disease.
Macrae FA
Med J Aust; 1982 Oct; 2(8):359. PubMed ID: 6128665
[No Abstract] [Full Text] [Related]
65. Managing ulcerative colitis.
Rogers AI
Compr Ther; 1976 Jun; 2(6):45-50. PubMed ID: 11055
[No Abstract] [Full Text] [Related]
66. Azathioprine and the treatment of chronic inflammatory bowel disease.
Lloyd-Still JD
J Pediatr; 1990 Nov; 117(5):732-5. PubMed ID: 2231203
[No Abstract] [Full Text] [Related]
67. [Crohn disease in children].
Kopeĭkin VN; Bogdanovich NE; Lukoianova GM; Kopylov MV; Sheliakhina NE
Pediatriia; 1991; (9):102-4. PubMed ID: 1684417
[No Abstract] [Full Text] [Related]
68. [Drug therapy for ulcerative colitis].
Shiratori T; Inatsugu N; Nishimura S; Hosoi T
Nihon Rinsho; 1977 May; 35(5):1867-71. PubMed ID: 18624
[No Abstract] [Full Text] [Related]
69. Is microscopic colitis due to bile-salt malabsorption?
Rampton DS; Baithun SI
Dis Colon Rectum; 1987 Dec; 30(12):950-2. PubMed ID: 3691268
[TBL] [Abstract][Full Text] [Related]
70. [Impaired absorption of bile acid in inflammatory bowel disease. Investigation by oral bile acid tolerance test].
Sasaki E
Nihon Shokakibyo Gakkai Zasshi; 1984 May; 81(5):1191-200. PubMed ID: 6471532
[No Abstract] [Full Text] [Related]
71. Absorption of dietary fats by the rat in cholestyramine-induced steatorrhea.
Harkins RW; Hagerman LM; Sarett HP
J Nutr; 1965 Sep; 87(1):85-92. PubMed ID: 5890965
[No Abstract] [Full Text] [Related]
72. Inflammatory disease of the bowel: treatable physiologic disorders following surgical treatment.
Brotman M
Dis Colon Rectum; 1976 Oct; 19(7):588-600. PubMed ID: 976027
[No Abstract] [Full Text] [Related]
73. Hyperoxaluria in malabsorptive states.
Andersson H; Bosaeus I
Urol Int; 1981; 36(1):1-9. PubMed ID: 7020204
[TBL] [Abstract][Full Text] [Related]
74. Comparison of two bile acid-binding agents, cholestyramine and lignin.
Heaton KW; Heaton ST; Barry RE
Clin Sci; 1970 Apr; 38(4):25P. PubMed ID: 5428798
[No Abstract] [Full Text] [Related]
75. Letter: Pellagra as the initial presentation of Crohn disease.
Rosmaninho A; Sanches M; Fernandes IC; Pinto-Almeida T; Vilaça S; Oliveira A; Selores M
Dermatol Online J; 2012 Apr; 18(4):12. PubMed ID: 22559027
[TBL] [Abstract][Full Text] [Related]
76. The comparative prophylactic effects of sulphasalazine, prednisolone and azathioprine in experimental colonic ulceration.
Watt J; Marcus SN; Marcus AJ
J Pharm Pharmacol; 1980 Dec; 32(12):873-4. PubMed ID: 6110761
[No Abstract] [Full Text] [Related]
77. Ulcerative colitis in childhood.
Chong SK; Walker-Smith JA
J R Soc Med; 1984; 77 Suppl 3(Suppl 3):21-5. PubMed ID: 6147413
[No Abstract] [Full Text] [Related]
78. A clinical scoring system for chronic inflammatory bowel disease in children.
Lloyd-Still JD; Green OC
Dig Dis Sci; 1979 Aug; 24(8):620-4. PubMed ID: 467213
[TBL] [Abstract][Full Text] [Related]
79. Treatment of sensorineural deafness associated with ulcerative colitis.
Dowd A; Rees WD
Br Med J (Clin Res Ed); 1987 Jul; 295(6589):26. PubMed ID: 2887230
[No Abstract] [Full Text] [Related]
80. Control of diarrhea by cholestyramine administration.
Rowe GG
Am J Med Sci; 1968 Jan; 255():84-8. PubMed ID: 5635295
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
